The Improved Experience You’ve Been Waiting For!
Discover the refreshed menu, enjoy the custom dashboard, and make use of the powerful stock screener to enhance your investment approach.
Explore Now
Blue Jet Healthcare Limited (BLUEJET:NSE) Stock Forecast
Alert
Its only available to paid users.
INR 600.00
(+17.77%)
Based on the Blue Jet Healthcare Limited stock forecast from 1 analysts, the average analyst target price for Blue Jet Healthcare Limited is INR 600.00 over the next 12 months. Blue Jet Healthcare Limited’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Blue Jet Healthcare Limited is Slightly Bullish , which is based on 6 positive signals and 4 negative signals. At the last closing, Blue Jet Healthcare Limited’s stock price was INR 509.45. Blue Jet Healthcare Limited’s stock price has changed by +4.21% over the past week, +8.34% over the past month and 0% over the last year.
No recent analyst target price found for Blue Jet Healthcare Limited
No recent average analyst rating found for Blue Jet Healthcare Limited
Company Overview Blue Jet Healthcare Limited
Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for applications in pharmaceutical and healthcare products. It provides integrated contrast media intermediates, saccharin and related salts, and niche pharmaceutical intermediates and APIs, as well as CDMO/CMO and development services. Blue Jet Healthcare Limited has operations in India, Norway, the United States, Sweden, Italy, Spain, and internationally. The company was incorporated in 1968 and is headquartered in Thane, India. Address: Bhumiraj Costarica, Plot No. 1 & 2, Thane, India, 400705 Read Less
Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for applications in pharmaceutical and healthcare products. It provides integrated contrast media intermediates, saccharin and related sa...Read More
N/A
N/A
0
N/A
INR
India
Adjusted Closing Price for Blue Jet Healthcare Limited (BLUEJET:NSE)
Loading...
Unadjusted Closing Price for Blue Jet Healthcare Limited (BLUEJET:NSE)
Loading...
Share Trading Volume for Blue Jet Healthcare Limited Shares
Loading...
Compare Performance of Blue Jet Healthcare Limited Shares
Symbol
Capital Gain
Dividend Return
Total Return
Loading...
Loading...
Technical Indicators for BLUEJET:NSE
Assets
Top Holdings
N/A
Top Sectors
Top Regions
Stocks Similar To Blue Jet Healthcare Limited (Sector: Biotechnology )
Frequently Asked Questions About Blue Jet Healthcare Limited (BLUEJET:NSE) Stock
Based on ratings from 1 analysts Blue Jet Healthcare Limited's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 1 buy, sell and hold ratings.
Unfortunately we do not have enough data on BLUEJET:NSE's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for BLUEJET:NSE is INR 600.00 over the next 12 months. The maximum analyst target price is INR 600 while the minimum anlayst target price is INR 600.
BLUEJET:NSE stock's Price/Earning ratio is 55.98.
Our analysis grades BLUEJET:NSE stock's Price / Earning ratio at F. This means that BLUEJET:NSE stock's Price/Earning ratio is above 55.00000000000001% of the stocks in the Biotechnology sector in the NSE exchange.
Based on this BLUEJET:NSE may be a overvalued for its sector.
The last closing price of BLUEJET:NSE's stock was INR 509.45.
The most recent market capitalization for BLUEJET:NSE is INR 88.51B.
Based on targets from 1 analysts, the average taret price for BLUEJET:NSE is projected at INR 600.00 over the next 12 months.
This means that BLUEJET:NSE's stock price may go up by +17.77% over the next 12 months.
We can't find any ETFs which contains Blue Jet Healthcare Limited's stock.
As per our most recent records Blue Jet Healthcare Limited has 0 Employees.
Sorry we do not have any infomation available on Blue Jet Healthcare Limited's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Blue Jet Healthcare Limited (BLUEJET:NSE) Stock
Based on ratings from 1 analysts Blue Jet Healthcare Limited's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 1 buy, sell and hold ratings.
Unfortunately we do not have enough data on BLUEJET:NSE's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for BLUEJET:NSE is INR 600.00 over the next 12 months. The maximum analyst target price is INR 600 while the minimum anlayst target price is INR 600.
BLUEJET:NSE stock's Price/Earning ratio is 55.98.
Our analysis grades BLUEJET:NSE stock's Price / Earning ratio at F. This means that BLUEJET:NSE stock's Price/Earning ratio is above 55.00000000000001% of the stocks in the Biotechnology sector in the NSE exchange.
Based on this BLUEJET:NSE may be a overvalued for its sector.
The last closing price of BLUEJET:NSE's stock was INR 509.45.
The most recent market capitalization for BLUEJET:NSE is INR 88.51B.
Based on targets from 1 analysts, the average taret price for BLUEJET:NSE is projected at INR 600.00 over the next 12 months.
This means that BLUEJET:NSE's stock price may go up by +17.77% over the next 12 months.
We can't find any ETFs which contains Blue Jet Healthcare Limited's stock.
As per our most recent records Blue Jet Healthcare Limited has 0 Employees.
Sorry we do not have any infomation available on Blue Jet Healthcare Limited's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BLUEJET:NSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
